T1 patients with CCR7-negative ESCC may be at a low risk of lymph node metastasis; therefore, they could receive less invasive therapy, thereby avoiding radical esophagectomy. This evidence concerns the gene CCR7 and metastatic malignant neoplasm in the lymph nodes.